SkinBioTherapeutics Stakeholder Acquires More Shares
Company Announcements

SkinBioTherapeutics Stakeholder Acquires More Shares

SkinBioTherapeutics (GB:SBTX) has released an update.

In a significant update from SkinBioTherapeutics PLC, David Campbell Brierwood has crossed a threshold in voting rights, now holding 3.1% of the company with 6,998,305 total voting rights as of August 12, 2024. This change in shareholding structure was formally notified to the company on the following day. No voting rights are held through financial instruments, indicating a straightforward equity stake.

For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskSkinBioTherapeutics Voting Rights Shift Slightly
TipRanks UK Auto-Generated NewsdeskSkinBioTherapeutics Expands with Strategic Acquisitions and Growth
TipRanks UK Auto-Generated NewsdeskSkinBioTherapeutics Gains Increased Stakeholder Interest
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App